A new model aims to predict stillbirth before it happens

NCT ID NCT07745101

Not yet recruiting Prevention Sponsor: RTI International Source: ClinicalTrials.gov ↗

First seen Aug 04, 2026 · Last updated Aug 05, 2026 · Updated 1 time

Summary

This study is developing a prediction model to identify pregnancies at increased risk of stillbirth or fetal growth restriction, often caused by placental problems. Researchers will follow 7,000 pregnant individuals, collecting data from early pregnancy through delivery and postpartum. The goal is to use clinical information, biomarkers, and placental examinations to create a risk score that could guide care and potentially prevent stillbirth.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: No drug or device; this is an observational study developing a risk prediction model using clinical data, biomarkers, and placental pathology.
What this could lead to: If successful, this could lead to a tool that identifies high-risk pregnancies early, allowing closer monitoring and interventions to prevent stillbirth.
What could go wrong: The prediction model may not be accurate enough for widespread use, and the study's findings might not apply to all populations. It is observational, so it cannot prove that any intervention reduces stillbirth.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for STILLBIRTH are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Stillbirth fetal growth restriction prevention target pregnancy disorder with abortive outcome prevention target

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

STILLBIRTH

Contacts and locations

Locations

Old Dominion University

Norfolk, Virginia, 23529, United States
Oregon Health & Science University

Portland, Oregon, 97239, United States
The Collaborative Action for Research to End Stillbirth (CARES) Research Center at Columbia University

New York, New York, 10027, United States
University of California Center for Stillbirth Prevention

San Diego, California, 92093, United States
University of Utah

Salt Lake City, Utah, 84112, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.